Erectile dysfunction management after failed phosphodiesterase-5-inhibitor trial : a cost-effectiveness analysis

Background: To evaluate the cost-effectiveness of alternate erectile dysfunction (ED) management options after failed first line phosphodiesterase-5-inhibitors (PDE5-I)

Bibliographic Details
Published in:Translational andrology and urology, Vol. 8, No. 4 (2019), p. 387-394
Main Author: Moses, Rachel A
Other Involved Persons: Anderson, Ross E ; Kim, Jaewhan ; Keihani, Sorena ; Craig, James R ; Myers, Jeremy B ; Lenherr, Sara M ; Brant, William O ; Hotaling, James M
Format: electronic Article
Language:English
ISSN:2223-4691
Item Description:Date Revised 29.09.2019
published: Print
Citation Status PubMed-not-MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
DOI:10.21037/tau.2019.03.10
Subjects:
QR Code: Show QR Code